SEC Form D filing

Akelos, Inc., 2026-03-16

An SEC Form D private-offering notice from New York, NY, an undisclosed offering target in Biotech. Filed 2026-03-16. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Akelos, Inc. site↗ Verified via SEC Form D

Biopharmaceutical company developing non-opioid, anti-hyperalgesic drugs for neuropathic pain, in research collaboration with Weill Cornell Medicine.

Filed 2026-03-16Filed to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2026-03-09Raised so far $1,486,000HQ (as filed) New York, NYSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified akelosinc.com↗Named in the filing 1 executive & director
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source